Market Size (2019)
—
Vertical: CNMBase Year: 201912 Sections
Market Size (2019)
—
Projected (2027)
—
CAGR (2018–2027)
N/A
Key Players
9+
This report covers Acrylate Monomer Market with forecasts from 2018 to 2027. 9 key companies are profiled.
Acrylate Monomer Market is a key focus area for market intelligence and strategic research.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAnalysis of Acrylate Monomer Market from 2018 to 2027. Covers South America, North America, Europe, Asia Pacific, Middle East and Africa.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistics agencies, and paid databases. This information creates a base for the study. The information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points which currently affect or are likely to affect the industry during the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation and forecast, which generates the quantitative figures/sizes of the market/sub-segments in the current scenario as well as for the forecast period.
After estimating the market sizes and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.
Data Mining
Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the components of the industry and their source, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.
Secondary Research
In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at Wantstats have access to some of the most diversified and extensive paid databases, which give us the most accurate data/ information on markets sizes, components, and pricing. Mentioned below is a detailed list of Sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data Sources depending on the need.
Primary Research
In the primary research process, in-depth primary interviews are conducted with the CXOs to understand the market share, customer base, pricing strategies, channel partners, and other necessary information. Besides, in-depth primary interviews are conducted with the CXOs of vendors, channel partners, and others to validate the supply-side information. In addition, various key industry participants from both the supply and demand side are interviewed to obtain qualitative and quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (SMEs), industry consultants, and C-level executives of major companies, are conducted to obtain critical qualitative and quantitative information pertaining to the market, as well as to assess the prospects for market growth during the forecast period. Detailed information on these primary respondents is mentioned below.
Breakdown of Primary Respondents
Forecasting Techniques
We at Wantstats follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting techniques as mentioned below.
Research Methodology for Market size estimation
Understanding the market in terms of valuation is a crucial task. This becomes significantly important while investing in and choosing the correct business opportunities. In this regard, we at Wantstats undertake two market sizing approaches simultaneously, namely, the top-down and bottom-up approaches. In this step, we assess different data points, numeric attributes, information, and industry trends to arrive at the estimates and forecast values for the coming years. We use different mathematical models to estimate the market sizes of different economies and segments, each of which is further summed up to define the total market.
We at Wantstats employ a proprietary statistical tool for market estimations, which helps us to arrive at market size estimates and forecasts for different markets and industries.
Bottom-UP approach
In the bottom-up approach, the revenue of key companies and their shares in the market are assessed to deduce the market size. More than 25 key players operating in the Global Acrylate Monomer market are studied. The segmental revenue of each player is analyzed and the size for the Global Acrylate Monomer market is extracted from the segmental/product revenue with the help of secondary and primary research. The extracted size for the market is then validated with industry experts and partner consultants. This derived market size contributes to around 65%–70% of the total global market share in terms of revenue for the Global Acrylate Monomer market. Using the data triangulation method, the overall global market size is estimated.
Top-Down approach
The overall market size is then used in the top-down procedure to estimate the size of the other sub-markets with the help of percentage splits of the market segments from secondary and primary research. The demand-side analysis is conducted, in which the expenditure of major industry players in each region is studied.
The countries considered in the scope of the Global Acrylate Monomer market are the US, Canada, Mexico, the UK, Germany, France, Italy, Spain, China, Japan, India, Australia & New Zealand, South Africa, Egypt, Nigeria, Saudi Arabia, Qatar, the UAE, Bahrain, Kuwait, and Oman, Brazil, Argentina, Chile, and others. However, the number of countries varies according to the market. The figure below depicts the process of market estimation using independent tools employed by our analysts to arrive at the sizing of the market.
As a part of the market engineering, the both top-down and bottom-up approaches are utilized along with data triangulation models to derive and verify the market sizes and forecast over the coming years.
Data Triangulation
After arriving at the overall market sizes, the total market is divided into several segments and sub-segments. Again, the market breakdown and data triangulation procedures are implemented, wherever applicable, to complete the overall market engineering process and gather the exact statistics for all segments and sub-segments. The data is triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size is validated using the top-down and bottom-up approaches.
Validation
Validation is the most important stage of the report making process. Validation via an intricately designed feedback process helps us finalize the sizing estimates and forecast for the final collation. Extensive primary research is performed to verify the information. This includes telephonic and personal interviews, e-mails, feedback forms, questionnaires, and polling options/answers with a group of relevant industry participants. Validation helps to duly check the authenticity of the key industry trends, market dynamics, company market share, different business models, and conclusions.
Base Year
2019
Historical Period
2018 – 2018
Forecast Period
2020 – 2027
Primary Interviews
150+
Historical data (2018–2019) and forecast period (2019–2027)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
See plans for professionals or small and medium businesses.

Analytical insights on Acrylate Monomer Market covering market dynamics, competitive landscape, and strategic outlook.
Acrylate Monomer Market represents a significant market opportunity with multiple growth drivers across regions and segments.
The scope of the global acrylate monomer study includes the market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on flavor, packaging type, distribution channel, and region.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 107 companies operating in the Acrylate Monomer Market market, including revenue, employee count, and market positioning where available.
Showing 107 of 107 companies
Evonik is Germany's second-largest listed chemicals group after BASF and one of Europe's broadest pure-play specialty chemicals companies, generating €14.1bn of sales and €1.87bn adjusted EBITDA in FY2025. Since April 2025 it has been organised into two operating segments — Custom Solutions (formulated, application-driven specialties for coatings, personal care, pharma, and industrial additives) and Advanced Technologies (scale- and technology-driven platforms in silica, hydrogen peroxide, high-performance polymers, crosslinkers and animal-nutrition amino acids) — plus an Infrastructure segment (SYNEQT site services, Oxeno C4 chemicals) earmarked for divestment. Its competitive identity rests on deep process know-how, integrated German Verbund sites (Marl, Wesseling, Rheinfelden, Essen, Hanau), and leadership positions in global niches (fumed silica, DL-methionine, PA12, pharma excipients/lipids). The investment case is a transformation story — €400m-plus cost reduction, portfolio pruning, deleveraging — now overlaid by a live takeover approach from BASF and a near-majority foundation shareholder whose stance is pivotal. --- ### Company self-description Evonik describes itself as a global chemical company that goes "beyond chemistry" by combining innovative strength with leading technological expertise, providing customers with a competitive advantage through tailor-made products and solutions — positioning itself as a "superforce for industry" (company boilerplate, press releases 2026; Company Factbook 2026). Its stated strategic pillars (Capital Markets Day, 22 May 2025) are: a differentiated portfolio in two segments, sustainable innovation, a balanced regional footprint (ambition of roughly one-third of sales in each of Americas, EMEA and Asia-Pacific), and a performance culture. ### Independent characterisation Evonik is a mid-cap, diversified specialty and "semi-specialty" chemicals manufacturer. Roughly 80% of FY2025 sales (€11.5bn of €14.1bn) came from the two core segments; the remaining ~18–19% came from Infrastructure & Other, which bundles low-margin site services and the cyclical C4 (Oxeno) petrochemical chain. The business is overwhelmingly a product business (manufactured chemicals sold B2B under supply contracts, frame agreements and spot), with smaller service/contract components: (i) pharma CDMO and contract manufacturing (Health Care — lipids/LNPs, drug substances, oral drug delivery), (ii) site infrastructure and utility services sold by SYNEQT to ~two dozen third-party companies in the Marl and Wesseling chemical parks, and (iii) licensing/technology (e.g., HPPO hydrogen peroxide technology with partners; catalysts). Subscription revenue is negligible. Precise revenue-model split (product vs service vs licensing) is n/d. ### Value-chain position Evonik sits mid-stream: it buys petrochemical feedstocks (C4 raffinate, propylene, methanol, ammonia, natural gas/energy, silicon metal, sulphur) and converts them into intermediates and formulated specialties sold to formulators and OEMs. Upstream integration is partial (own C4 cracking downstream of refinery/cracker streams at Marl and Antwerp; own HCN and methionine chain in Antwerp, Mobile and Singapore). Downstream, it rarely sells to consumers; its products are ingredients typically <5% of the customer's cost but critical to performance ("small cost share, high value-in-use"), which supports pricing power in the specialty businesses. ### Customer types and end markets Customers include paint and coatings formulators, adhesives and sealants makers, tyre and rubber producers (silica/silanes), cosmetic and household-care brands, pharmaceutical and biotech companies (excipients, lipids, CDMO), animal-feed mills and integrators (methionine), plastics and automotive suppliers (PA12, PEEK), aerospace (ROHACELL foams), pulp & paper, electronics and semiconductors (high-purity silanes/chlorosilanes, H2O2), renewable energy and hydrogen (membranes, catalysts), and biodiesel producers (alkoxide catalysts). End-market exposure is broad: consumer/personal care, health care, food/feed, automotive and mobility, construction, coatings, industrial, energy/agriculture. A precise end-market % split for FY2025 is n/d in sources reviewed.
Company Headquarters: Michigan, US Founded: 1897 Workforce: ~ 35,700 Company Working: Dow Chemical Company provides various materials science solutions for packaging, infrastructure, mobility, and consumer Mineral Types in the United States, Canada, Europe, the Middle East, Africa, India, the Asia Pacific, and South America. It operates through Packaging & Specialty Plastics, mining, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings segments. Dow offers a comprehensive portfolio of mining chemicals designed to enhance mineral processing efficiency, extract valuable minerals, and address environmental and safety challenges. These chemicals include frothers, collectors, dispersants, depressants, solvent extractants, and scale inhibitors, among others. The Packaging & Specialty Plastics segment provides ethylene, and propylene and aromatics products, and polyethylene, polyolefin elastomers, ethylene vinyl acetate, and ethylene propylene diene monomer rubbers. The Industrial Intermediates & Infrastructure segment offers ethylene oxides, propylene oxides, propylene glycol and polyether polyols, aromatic isocyanates and polyurethane systems, coatings, adhesives, sealants, elastomers, and composites. This segment also provides caustic soda, ethylene dichloride and vinyl chloride monomers, cellulose ethers, redispersible latex powders, and acrylic emulsions. The Performance Materials and Coatings segment provides architectural paints and coatings, and industrial coatings that are used in maintenance and protective industries, wood, metal packaging, traffic markings, thermal paper, and leather; performance silicones and specialty materials; and silicone feedstocks and intermediates. It also engages in property and casualty insurance, as well as reinsurance business.
Mitsubishi Chemical Corporation is the chemicals engine of Japan's largest diversified chemical group, Mitsubishi Chemical Group. Following the July 2025 sale of Mitsubishi Tanabe Pharma to Bain Capital for roughly JPY 510 billion, the group has narrowed to two pillars: chemicals (run through MCC) and industrial gases (run through ~50%-owned, separately listed Nippon Sanso Holdings). MCC operates three reporting segments — Specialty Materials (engineering plastics, films, carbon fiber composites, semiconductor process materials and services, food-packaging polymers), MMA & Derivatives (a global leader in methyl methacrylate and PMMA) and Basic Materials & Polymers (ethylene, polyolefins, coal chemicals). Under "KAITEKI Vision 35" and the Medium-Term Management Plan 2029, management is pursuing a "Green Specialty" identity: harvesting and restructuring commoditised petrochemical, coke and MMA assets while investing in semiconductor, mobility and food-preservation materials. FY2025 profits were depressed by restructuring charges, but Q1 FY2026 core operating income more than doubled year-on-year. --- ### What the company does Mitsubishi Chemical Group is a holding company whose consolidated revenue (JPY 3,704.0bn in FY2025) comes from four reportable segments. Three are operated by Mitsubishi Chemical Corporation (Specialty Materials; MMA & Derivatives; Basic Materials & Polymers), and the fourth (Industrial Gases) is operated by Nippon Sanso Holdings and its subsidiaries (Taiyo Nippon Sanso in Japan, Matheson Tri-Gas in the US, Nippon Gases in Europe, plus Asia-Oceania operations including Coregas in Australia/New Zealand from July 2025). The former Pharma segment was reclassified as discontinued operations after the transfer of Mitsubishi Tanabe Pharma's business on 1 July 2025. FY2025 segment revenue mix (Yuho FY2025, external revenue basis per EDINET-derived data): Industrial Gases ~37–38%, Specialty Materials ~29–30%, Basic Materials & Polymers ~21–22%, MMA & Derivatives ~10%. The striking feature of the current profile is the asymmetry between revenue and profit: Industrial Gases delivered JPY 200.7bn of the group's JPY 225.0bn FY2025 core operating income (~89%), while the three MCC-run chemical segments combined (including corporate/other) contributed only JPY 24.3bn. MCC's investment case therefore rests on restoring chemical-segment profitability, which management guides to JPY 100bn in FY2026. ### Business and revenue model ### Customer types and end-markets Customers are predominantly B2B manufacturers: semiconductor device makers and equipment OEMs; display and electronics makers; automotive OEMs and Tier-1s (including electric-vehicle and robotaxi programmes); food and beverage packaging converters; medical/cell-culture device makers; construction and coatings formulators; and steelmakers (coke, industrial gases). End-markets highlighted by management in FY2025: semiconductors (precision cleaning, high-performance engineering plastics for semiconductor manufacturing equipment, synthetic quartz, GaN substrates), mobility (carbon-fibre composite parts, DURABIO bio-based polycarbonate — adopted by Audi for Q3 door-switch inserts in June 2026), food quality preservation (Soarnol EVOH barrier resin, films), healthcare/life sciences, and AI data-centre optical interconnects (investment in NLM Photonics, 2026). ### Company's own description vs. independent characterisation The group describes itself under KAITEKI Vision 35 as aiming to become a "Green Specialty Company," with CEO Chikumoto framing the current phase as a return to "fundamentals-focused" management — clear profit responsibility for every business and a "lean and strong" organisation (Nomura Asset Management interview, 2025–26). Independent characterisation: In practice MCG today is a gases-funded chemical restructuring story. A high-quality, mid-teens-margin industrial-gas annuity (consolidated but ~50% minority-owned) masks a chemical portfolio that in FY2025 earned a low-single-digit core margin and booked roughly JPY 195bn of non-recurring losses (core-to-reported operating income bridge). The equity story hinges on (a) Specialty Materials compounding from JPY 23.9bn (FY2024) toward management's JPY 144bn FY2029 ambition, (b) the MMA cycle bottoming, and (c) completing the exit or consolidation of structurally challenged commodity assets (coke, Mizushima ethylene, basic petrochemicals spin-off).
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
Nippon Shokubai is a mid-cap Japanese chemical producer built on proprietary gas-phase oxidation catalyst technology, its name literally means "Japan Catalyst". It is one of the world's largest producers of superabsorbent polymer (SAP), the absorbent core of disposable diapers; the company is widely described as holding the No. 1 global share. It is also vertically integrated upstream into acrylic acid (AA) and ethylene oxide (EO). Roughly 70% of FY2025 revenue (JPY 278.8bn of JPY 399.9bn) came from the cyclical, spread-driven Materials segment, which produces at plants in Japan, the US, Belgium, Indonesia, China, Singapore and South Korea. The remaining c.30% came from Solutions: higher-margin functional chemicals, including concrete-admixture polymers, electronic and display materials, iodine compounds, De-NOx catalysts and the IONEL™ lithium salt (LiFSI) for lithium-ion battery electrolytes. Under Mid-Term Management Plan 2027, management is reallocating capital toward Solutions, targeting over 50% of profit from that segment. This is a classic portfolio transformation from commodity to specialty, set against a backdrop of sub-cost-of-equity ROE (4.3% in FY2025) and a price-to-book ratio that has traded below 1.0x. --- ### Company's own description (Yuho FY2025 / Integrated Report 2025 themes) The group runs two reportable segments. **Materials Business.** It manufactures and sells: - acrylic acid, acrylic esters, ethylene oxide, ethylene glycol and ethanolamines; - specialty esters, superabsorbent polymers, maleic anhydride and process catalysts. Nippon Shokubai Trading purchases and resells these products and supplies raw materials. The company describes the business as providing high-quality materials worldwide through sophisticated production technologies. Its stated aim under the Mid-Term Management Plan 2027 is to strengthen profitability through production-system reorganisation, sales expansion in growth markets and alliances. **Solutions Business.** It manufactures and sells: - polymers for concrete admixtures, glycol ethers, secondary alcohol ethoxylates, and water-soluble polymers for detergent raw materials; - pharmaceutical intermediates, electronic information materials, iodine compounds, and resins for adhesives and coatings; - ethyleneimine derivatives and adhesive-processed products; - automotive catalysts, De-NOx catalysts, dioxin-decomposition catalysts, exhaust-gas treatment equipment and wet-oxidation catalysts; - battery materials. The company frames this segment as providing unique functional products by capitalising on its strengths in developing key materials. The corporate philosophy is "TechnoAmenity": providing affluence and comfort to people and society through technology. The long-term vision to 2030 rests on three pillars: business transformation, environmental transformation and organisational transformation. ### Independent characterisation **Business model.** Nippon Shokubai is fundamentally a product manufacturer. Revenue is almost entirely product sales, with no meaningful subscription component. A modest technology-licensing element exists. The company develops core AA/SAP process and catalyst technology in-house and licenses it to its consolidated and equity-method production sites. Process-catalyst sales to third parties also exist inside Materials. External licensing revenue is not separately disclosed. The Solutions segment also contains small engineering/equipment revenue (exhaust-gas treatment equipment). It is moving into contract manufacturing for mid-molecular APIs (oligonucleotides and peptides), which is a service-like model. **Value-chain position.** - *Materials:* mid-stream. The company buys propylene (for AA) and ethylene (for EO), both naphtha-linked, from refiners and crackers, and converts them via proprietary catalytic oxidation. It sells either merchant AA/AES/EO/EG or captively converts AA into SAP. Earnings are driven by the spread between product prices and naphtha/propylene costs, plus inventory valuation effects. - *Solutions:* further downstream. Products are specified into customer formulations, such as cement admixtures, display/semiconductor materials, detergents and battery electrolytes. These are typically sold on performance rather than spec price. **Customer types.** - Global hygiene majors (diaper/feminine-care producers) for SAP. Customer names are not disclosed, but the industry is concentrated among a few multinationals. - Coatings, adhesives, fibre and plastics producers for AA/esters. - Polyester and antifreeze producers for EG. - Detergent and personal-care formulators. - Cement and concrete admixture formulators and the construction industry. - Electronics and display panel makers and semiconductor materials users. - Lithium-ion battery and electrolyte makers (EV and energy-storage). - Pharmaceutical companies (intermediates, oligonucleotide APIs). - Power utilities and incinerator operators (De-NOx and dioxin catalysts). **End-markets.** Hygiene (diapers, adult incontinence), construction and civil engineering, automotive and EV, electronics and displays, energy storage, household detergents, pharmaceuticals and healthcare, coatings and adhesives, and environmental protection.
New Japan Chemical is a 107-year-old, Kyoto/Osaka-based specialty and commodity chemical manufacturer whose core competences are high-pressure hydrogenation, acid-anhydride chemistry, esterification and polymer-additive modification, applied to both natural fats/oils (oleochemicals) and petrochemical feedstocks. It sells fatty acids, natural higher and unsaturated alcohols, surfactants for toiletries, PVC plasticizers, resin raw materials (acid anhydrides, hydrogenated bisphenol-type monomers) and resin additives (nucleating/crystallization agents) into housing materials, automotive, electronics/semiconductor, personal care and lubricant markets. With JPY 32.1bn of FY2026 revenue and only 394 employees, it is a micro-cap (≈JPY 9bn market value) trading at roughly 0.45× book. Profitability is structurally thin (operating margin 1.8% in FY2026) because roughly 73% of sales are bulk chemicals exposed to Asian import competition. Management's 2026–2030 plan aims to pivot the mix to fine chemicals, lifting operating margin to 5% and ROE to 7% by FY2031 (company "2030年度"). --- **Company's own description (Annual Securities Report, FY2026).** The group comprises the parent, six subsidiaries and three affiliates. Products made mainly from natural fats and oils are fatty acids, higher alcohols, unsaturated alcohols and surfactants, produced by the parent and subsidiaries Nisshin Rika and Nitto Kasei Kogyo, with some product sourced from affiliate Edenor Oleochemicals Rika (Malaysia) and from the market. Products made mainly from petrochemicals are plasticizers, functional products and resin additives, produced by the parent and Nisshin Rika, with some purchased product resold. The group reports as a single segment. **Independent characterization.** NJC is a mid-stream chemical converter. It buys commodity feedstocks (palm/coconut-derived oils and fatty materials; naphtha-derived phthalic/cyclic anhydrides, alcohols and aromatics), applies hydrogenation, esterification, distillation and purification, and sells intermediates to formulators and compounders. It sits between global feedstock producers (Southeast Asian oleochemical majors, Japanese petrochemical crackers) and branded consumer-goods, PVC-compounding, coating, electronics and automotive-parts makers. Its economic model is therefore a spread business in bulk lines (price minus raw-material cost, sensitive to naphtha, vegetable-oil prices and JPY/USD) layered with a small but growing specialty business where it earns pricing power from proprietary chemistry (e.g., dianhydrides for photosensitive polyimides, crystallization promoters, high-heat plasticizers, HDD lubricants). **Revenue model mix.** Essentially 100% product sales (manufactured and merchanted). No service, subscription or licensing revenue is reported; management's IP strategy ("IP Forecast", "profit-centre" IP) signals an intent to monetize patents via collaboration, but no licensing income is disclosed. **Management's portfolio split (FY2026, company "2025年度"):** Source: FY3/2026 Results & MTP presentation, 27 May 2026, p.15. The same slide indicates fine chemicals are expected to account for a disproportionate share of operating profit (presentation shows long-run targets of fine chemicals at 60% of sales/75% of profit toward 2035; the exact allocation of percentages to years is not fully legible in the extracted text and should be confirmed against the original slide). **Customer types and end-markets** (FY2026 MD&A): - Toiletry/personal-care formulators (surfactants, high-function cosmetic raw materials). - PVC compounders and building-material makers — flooring, wallpaper, wire & cable insulation (general-purpose plasticizers); automotive and heat-resistant applications (functional plasticizers). - Automotive supply chain (resin additives, high-heat plasticizers, crystallization promoter RiKACRYSTA adopted in auto parts). - Electronics/semiconductor and display materials (acid anhydrides/dianhydrides, optical adjusters). - Industrial users (textile-oil raw materials via natural higher alcohols — being exited). - Medical raw materials (cited as a high-function growth product in FY2026). - Concentration: Showa Kasei Kogyo accounted for JPY 3,422M (10.5%) of FY2025 sales; it fell below 10% in FY2026.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)